AACR Journals Metrics

According to Clarivate Analytics' 2017 Journal Citation Reports® (Clarivate Analytics 2018), publications from the American Association for Cancer Research (AACR) continue to be rated among the most influential journals in cancer research and medicine. The entire portfolio of AACR journals, which represent 4% of the 222 journals in the Oncology category, garnered 15% of all citations in the same category. One half of the AACR journals rank in the top 8% in regard to Impact Factor in the Oncology category. Cancer Discovery received an Impact Factor of 24.373, up 22% from last year, and ranks 6th in the Oncology category. Clinical Cancer Research ranks 12th with an Impact Factor of 10.199. Cancer Immunology Research jumped up 11% from last year with an Impact Factor of 9.188, ranking 16th. Cancer Research's ranks 17th with an Impact Factor of 9.130.

Impact Factor:

As reported in the most recent release of the JCR, four of the eight AACR journals rank in the top 8% of oncology journals with regard to Impact Factor.

*Cancer Epidemiology, Biomarkers & Prevention is also ranked in the Public, Environmental and Occupational Health category in JCR.

Five-Year Impact Factor:

While the standard Impact Factor measures citations to journal articles published within a 2-year period, the 5-year Impact Factor evaluates citations to journal articles published within a 5-year period to provide a measure of a journal's longer-term influence. Cancer Discovery, Cancer Immunology Research, Clinical Cancer Research, and Cancer Research rank within the top 7% in the Oncology category for 5-year Impact Factor.

aCancer Epidemiology, Biomarkers & Prevention is also ranked in the Public, Environmental and Occupational Health category in JCR.

Eigenfactor:

The Eigenfactor uses methods from network theory to rank the influence of journals, much as Google's PageRank algorithm ranks the influence of web pages, by identifying journals as influential if they are cited often by other influential journals. Clinical Cancer Research and Cancer Research rank 3rd and 4th, respectively, by Eigenfactor in the Oncology category.

aCancer Epidemiology, Biomarkers & Prevention is also ranked in the Public, Environmental and Occupational Health category in JCR.

Immediacy Index:

An Immediacy Index is a measure of how topical and urgent work published in a scientific journal is. The Immediacy Index is calculated by dividing the number of citations to articles published in a given year by the number of articles published in that year. Cancer Discovery, Clinical Cancer Research, and Cancer Research rank in the top 25 of the 222 journals in the Oncology category in terms of Immediacy Index.